Quarterly ResultMay 12, 2026, 04:14 PM
REVVITY Q1 Revenue +7% to $711.1M; Net Income $40.7M
AI Summary
REVVITY, INC. reported a 7% increase in total revenue to $711.1 million for the first quarter of fiscal year 2026, compared to $664.8 million in the prior year. Net income, however, decreased by 3.6% to $40.7 million. The company completed the acquisition of Advanced Chemistry Development Inc. for $72.0 million and initiated restructuring efforts affecting approximately 2% of its workforce.
Key Highlights
- Total revenue increased 7% to $711.1 million for Q1 2026.
- Net income decreased 3.6% to $40.7 million for Q1 2026.
- Diluted EPS rose to $0.36 in Q1 2026 from $0.35 in Q1 2025.
- Acquired Advanced Chemistry Development Inc. for $72.0 million cash.
- Restructuring costs were $10.7 million, affecting 2% of workforce.
- Repurchased 784,142 shares for $79.0 million under a $1.0 billion program.
- Life Sciences segment revenue grew 6.3% to $361.8 million.
- Diagnostics segment revenue grew 7.7% to $349.3 million.